Market Overview

Illumina Signs Master Supply Agreement with LabCorp

Share:
Related ILMN
Benzinga's Top Initiations
Burning Rock, Illumina Announce Collaboration on Molecular Diagnostics for Oncology
Premarket Biotech Digest: Anti-CD Antigen Therapy, Geron Files S-3, 3 MAAs In EU (Seeking Alpha)

Illumina (NASDAQ: ILMN) today announced it has entered into a
multi-year supply agreement with Laboratory Corporation of America®
Holdings (LabCorp®) (NYSE: LH). The agreement gives LabCorp expanded
rights to use Illumina next-generation sequencing (NGS) and microarray
equipment and supplies to develop, validate and introduce
laboratory-developed tests to clinicians in the United States and Canada.

See full press release

Posted-In: News Guidance Offerings Contracts Management Global

 

Related Articles (ILMN + LH)

View Comments and Join the Discussion!

Get Benzinga's Newsletters